<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(2)</volume><submitter>Behringer T</submitter><pubmed_abstract>To examine the impact of physician counseling on perceived risks, benefits, and likelihood of use of anxiolytic pharmacotherapy during pregnancy among women with a history of anxiety. We surveyed 96 nonpregnant women, aged 21-45 years, with panic disorder and/or generalized anxiety disorder (DSM-IV criteria) recruited by their family physicians to participate in an anxiety treatment trial from 7 primary care practices in Pittsburgh, Pennsylvania. Trained research assistants telephoned study participants to assess sociodemographics, psychiatric history, comorbidities, and anxiety severity. Respondents were asked to assess risks, benefits, and likelihood of taking a prescribed anxiolytic during pregnancy using 3 Likert scales at baseline. Respondents were then asked to indicate whether their</pubmed_abstract><journal>The primary care companion for CNS disorders</journal><pagination>PCC.10m01028</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3184592</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.</pubmed_title><pmcid>PMC3184592</pmcid><pubmed_authors>Rollman BL</pubmed_authors><pubmed_authors>Mazumdar S</pubmed_authors><pubmed_authors>Behringer T</pubmed_authors><pubmed_authors>Schwarz EB</pubmed_authors><pubmed_authors>Herbeck-Belnap B</pubmed_authors><pubmed_authors>Houck PR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.</name><description>To examine the impact of physician counseling on perceived risks, benefits, and likelihood of use of anxiolytic pharmacotherapy during pregnancy among women with a history of anxiety. We surveyed 96 nonpregnant women, aged 21-45 years, with panic disorder and/or generalized anxiety disorder (DSM-IV criteria) recruited by their family physicians to participate in an anxiety treatment trial from 7 primary care practices in Pittsburgh, Pennsylvania. Trained research assistants telephoned study participants to assess sociodemographics, psychiatric history, comorbidities, and anxiety severity. Respondents were asked to assess risks, benefits, and likelihood of taking a prescribed anxiolytic during pregnancy using 3 Likert scales at baseline. Respondents were then asked to indicate whether their</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011</publication><modification>2025-04-26T20:45:22.962Z</modification><creation>2019-03-27T00:44:31Z</creation></dates><accession>S-EPMC3184592</accession><cross_references><pubmed>21977355</pubmed><doi>10.4088/pcc.10m01028</doi><doi>10.4088/PCC.10m01028</doi></cross_references></HashMap>